Philippines - English - FDA (Food And Drug Administration)

genasia biotech l.l. corp. - anagrelide (as hydrochloride) - capsule - 500mcg

Philippines - English - FDA (Food And Drug Administration)

globo asiatico enterprises inc.; distributor: globo asiatico enterprises inc. - anagrelide (as hydrochloride) - capsule - 500mcg

European Union - English - EMA (European Medicines Agency)

shire pharmaceuticals ireland limited - anagrelide - thrombocythemia, essential - antineoplastic agents, - xagrid is indicated for the reduction of elevated platelet counts in at-risk essential-thrombocythaemia (et) patients who are intolerant to their current therapy or whose elevated platelet counts are not reduced to an acceptable level by their current therapy. an at-risk patient an at-risk et is defined by one or more of the following features: >60 years of age or;, a platelet count >1000 x 109/l or;, a history of thrombohaemorrhagic events.,

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: torrent pharma philippines, inc.; distributor: torrent pharma philippines, inc. - anagrelide (as hydrochloride) - capsule - 500 mcg

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: i.e. medica, inc.; distributor: i.e. medica, inc. - anagrelide (as hydrochloride) - tablet - 500 mcg

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: i.e. medica, inc; distributor: i.e. medica, inc - anagrelide (as hydrochloride) - tablet - 500 mcg

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

takeda pharmaceutical company limited. - anagrelide hydrochloride hydrate - white hard capsule, major axis: approx. 14.3 mm, minor axis: approx. 5.32 mm

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

key oncologics (pty) ltd - capsules - see ingredients - each capsule contains anagrelide hydrochloride equivalent to anagrelide 0,5 mg

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - indapamide hemihydrate 2.5mg - tablet - 2.5 mg - active: indapamide hemihydrate 2.5mg excipient: croscarmellose sodium lactose magnesium stearate microcrystalline cellulose opadry pink oy-6953 purified water sodium starch glycolate - essential hypertension. it may be tried as a sole therapeutic agent in the treatment of mild to moderate hypertension. normally indapamide is used as the initial agent in multiple drug regimens.

New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - pentoxifylline 400mg;  ;   - modified release tablet - 400 mg - active: pentoxifylline 400mg     excipient: erythrosine hyetellose hypromellose macrogol 8000 magnesium stearate povidone purified talc   purified water   titanium dioxide - the treatment of peripheral occlusive vascular disease and circulatory disorders of arteriosclerotic, diabetic, inflammatory or function origin; trophic disorders (e.g., leg ulcers and gangrene).